Trial
NCT02676310
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Allergan
Collaborators
—
Condition
Alopecia
Intervention
Bimatoprost
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-17